These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25749560)

  • 21. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
    Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
    Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus genotypes in Southeast Brazil and its relationship with histological features.
    Nabuco LC; Mello FC; Gomes Sde A; Perez RM; Soares JA; Coelho HS; Nogueira CA
    Mem Inst Oswaldo Cruz; 2012 Sep; 107(6):785-9. PubMed ID: 22990965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.
    Zhao Q; Fan YC; Zhao J; Gao S; Zhao ZH; Wang K
    J Viral Hepat; 2013 Jun; 20(6):430-7. PubMed ID: 23647960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity.
    Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E
    Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
    Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
    Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
    Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
    J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels.
    Du X; Wang J; Shao L; Hu X; Yang C; Shen L; Weng X; Zhang W
    J Viral Hepat; 2013 May; 20(5):328-35. PubMed ID: 23565615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B.
    Eminler AT; Irak K; Ayyildiz T; Keskin M; Kiyici M; Gurel S; Gulten M; Dolar E; Nak SG
    Turk J Gastroenterol; 2014 Aug; 25(4):411-5. PubMed ID: 25254524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inter-observes agreement of Ishak and Metavir scores in histological evaluation of chronic viral hepatitis B and C].
    Rammeh S; Khadra HB; Znaidi NS; Romdhane NA; Najjar T; Bouzaidi S; Zermani R
    Ann Biol Clin (Paris); 2014; 72(1):57-60. PubMed ID: 24492098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
    Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
    J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses].
    Siutkin VE; Lopatkina TN; Popova IV
    Arkh Patol; 1998; 60(6):37-41. PubMed ID: 9949904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
    Tan Y; Ye Y; Zhou X; Chen L; Wen D
    PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy.
    Sigal SH; Ala A; Ivanov K; Hossain S; Bodian C; Schiano TD; Min AD; Bodenheimer HC; Thung SN
    Liver Transpl; 2005 Jan; 11(1):82-8. PubMed ID: 15690540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.
    Hui CK; Zhang HY; Lee NP; Chan W; Yueng YH; Leung KW; Lu L; Leung N; Lo CM; Fan ST; Luk JM; Xu A; Lam KS; Kwong YL; Lau GK;
    J Hepatol; 2007 Aug; 47(2):191-202. PubMed ID: 17462782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver steatosis in patients with chronic hepatitis B infection: host and viral risk factors.
    Minakari M; Molaei M; Shalmani HM; Mohammad Alizadeh AH; Jazi AH; Naderi N; Shavakhi A; Mashayekhi R; Zali MR
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):512-6. PubMed ID: 19190500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Ma J; Jiang Y; Gong G
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):428-34. PubMed ID: 23358121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of chronic coinfection with hepatitis B and C virus on liver histology.
    Sagnelli E; Pasquale G; Coppola N; Scarano F; Marrocco C; Scolastico C; Santantonio T; Gentile A; Piccinino F
    Infection; 2004 Jun; 32(3):144-8. PubMed ID: 15188073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.